Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GALECTO BIOTECH ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.2% 1.2% 1.2% 1.2% 1.2% 1.2% 1.2% 1.2%   Bankruptcy risk   3.6% 4.0% 3.7% 2.9% 1.6% 2.6% 8.1% 8.1%   Credit score (0-100)   54 51 51 57 74 60 30 30   Credit rating   BBB BBB BBB BBB A BBB BB BB   Credit limit (kEUR)   0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kEUR)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,465 2,423 4,884 9,407 12,287 15,257 0.0 0.0   EBITDA   283 369 481 810 1,052 2,340 0.0 0.0   EBIT   283 369 481 810 1,019 2,109 0.0 0.0   Pre-tax profit (PTP)   608.3 323.9 213.7 764.8 908.9 2,094.9 0.0 0.0   Net earnings   474.4 323.9 213.7 764.8 818.7 849.4 0.0 0.0   Pre-tax profit without non-rec. items   608 369 481 810 909 2,095 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kEUR)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 255 0.0 0.0 0.0   Shareholders equity total   2,354 2,690 2,904 3,669 7,394 8,243 8,233 8,233   Interest-bearing liabilities   1,730 0.0 0.0 0.0 1,168 0.0 0.0 0.0   Balance sheet total (assets)   4,435 4,085 5,467 6,427 9,899 10,668 8,233 8,233   Net Debt   -1,870 0.0 0.0 0.0 -2,261 -2,968 -8,233 -8,233     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,465 2,423 4,884 9,407 12,287 15,257 0.0 0.0   Gross profit growth   0.0% 65.4% 101.5% 92.6% 30.6% 24.2% -100.0% 0.0%   Employees   5 11 16 29 36 37 0 0   Employee growth %   25.0% 120.0% 45.5% 81.3% 24.1% 2.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,435 4,085 5,467 6,427 9,899 10,668 8,233 8,233   Balance sheet change%   204.8% -7.9% 33.8% 17.6% 54.0% 7.8% -22.8% 0.0%   Added value   283.4 369.5 481.0 809.7 1,018.6 2,340.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 222 -487 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.3% 15.2% 9.8% 8.6% 8.3% 13.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.7% 8.7% 10.1% 13.6% 14.8% 23.2% 0.0% 0.0%   ROI %   16.5% 9.0% 10.1% 13.6% 16.2% 28.3% 0.0% 0.0%   ROE %   24.9% 12.8% 7.6% 23.3% 14.8% 10.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   53.1% 100.0% 100.0% 100.0% 74.7% 77.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -660.0% 0.0% 0.0% 0.0% -215.0% -126.8% 0.0% 0.0%   Gearing %   73.5% 0.0% 0.0% 0.0% 15.8% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.6% 0.0% 0.0% 0.0% 51.9% 49.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   12.1 0.0 0.0 0.0 7.6 4.5 0.0 0.0   Current Ratio   12.1 0.0 0.0 0.0 7.6 4.5 0.0 0.0   Cash and cash equivalent   3,600.0 0.0 0.0 0.0 3,428.8 2,968.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,061.8 0.0 0.0 0.0 8,324.9 8,275.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   57 34 30 28 28 63 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   57 34 30 28 29 63 0 0   EBIT / employee   57 34 30 28 28 57 0 0   Net earnings / employee   95 29 13 26 23 23 0 0